X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (9632) 9632
Book Review (2743) 2743
Publication (1013) 1013
Newspaper Article (175) 175
Book Chapter (86) 86
Newsletter (54) 54
Conference Proceeding (25) 25
Book / eBook (20) 20
Magazine Article (20) 20
Dissertation (17) 17
Trade Publication Article (5) 5
Government Document (2) 2
Reference (2) 2
Paper (1) 1
Presentation (1) 1
Web Resource (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (8602) 8602
male (6593) 6593
humans (6426) 6426
animals (3565) 3565
prostate cancer (2915) 2915
androgens (2610) 2610
female (2439) 2439
prostatic neoplasms - drug therapy (2301) 2301
androgen antagonists - therapeutic use (1999) 1999
testosterone (1835) 1835
oncology (1758) 1758
aged (1669) 1669
endocrinology & metabolism (1594) 1594
middle aged (1521) 1521
rats (1463) 1463
androgen receptor (1458) 1458
urology & nephrology (1436) 1436
cancer (1351) 1351
androgen antagonists - administration & dosage (1285) 1285
prostatic neoplasms - pathology (1282) 1282
care and treatment (1161) 1161
adult (990) 990
mice (987) 987
abridged index medicus (937) 937
research (932) 932
treatment outcome (929) 929
receptors, androgen - metabolism (906) 906
androgen antagonists - pharmacology (846) 846
estrogen (785) 785
men (778) 778
aged, 80 and over (769) 769
pharmacology & pharmacy (769) 769
prostate (769) 769
testosterone - blood (765) 765
androgen antagonists - adverse effects (764) 764
analysis (761) 761
health aspects (755) 755
orchiectomy (734) 734
androgen (708) 708
article (684) 684
metastasis (656) 656
prostate-specific antigen - blood (653) 653
hormones (648) 648
expression (641) 641
antineoplastic agents, hormonal - therapeutic use (633) 633
castration (619) 619
prostatic neoplasms - therapy (619) 619
dose-response relationship, drug (598) 598
carcinoma (597) 597
therapy (592) 592
cell line, tumor (589) 589
prostatic neoplasms - metabolism (577) 577
physiological aspects (553) 553
flutamide (552) 552
risk factors (550) 550
biochemistry & molecular biology (539) 539
testosterone - pharmacology (525) 525
time factors (525) 525
neurosciences (504) 504
androgens - metabolism (501) 501
urology (498) 498
chemotherapy (496) 496
androgens - pharmacology (475) 475
receptors, androgen - genetics (468) 468
androgen deprivation therapy (465) 465
medicine & public health (464) 464
gene expression (460) 460
cell biology (459) 459
pregnancy (453) 453
toxicology (446) 446
prostatic neoplasms - blood (444) 444
rats, sprague-dawley (442) 442
radiotherapy (435) 435
apoptosis (432) 432
prostatic neoplasms - mortality (432) 432
radical prostatectomy (422) 422
antineoplastic agents, hormonal - administration & dosage (403) 403
cancer therapies (403) 403
gene-expression (403) 403
drug therapy (400) 400
antineoplastic combined chemotherapy protocols - therapeutic use (398) 398
disease progression (395) 395
drug administration schedule (394) 394
antineoplastic agents - therapeutic use (390) 390
estradiol (387) 387
flutamide - pharmacology (387) 387
prostatic neoplasms - surgery (377) 377
survival (368) 368
cells (362) 362
quality of life (362) 362
neoplasm staging (355) 355
androgen-deprivation therapy (353) 353
combined modality therapy (353) 353
reproductive biology (351) 351
antiandrogens (350) 350
tumors (348) 348
clinical trials (346) 346
prostate-cancer (346) 346
obstetrics & gynecology (345) 345
rodents (344) 344
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (9620) 9620
German (102) 102
Japanese (93) 93
French (48) 48
Russian (31) 31
Spanish (17) 17
Italian (13) 13
Chinese (9) 9
Hungarian (9) 9
Polish (6) 6
Ukrainian (5) 5
Czech (4) 4
Swedish (4) 4
Bulgarian (3) 3
Danish (3) 3
Portuguese (3) 3
Croatian (2) 2
Norwegian (2) 2
Afrikaans (1) 1
Arabic (1) 1
Dutch (1) 1
Hebrew (1) 1
Persian (1) 1
Serbian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 07/2017, Volume 377, Issue 4, pp. 352 - 360
Journal Article
Molecular Cancer Research, ISSN 1541-7786, 04/2016, Volume 14, Issue 4, pp. 324 - 331
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 10/2013, Volume 19, Issue 19, pp. 5505 - 5512
Journal Article
Lancet, The, ISSN 0140-6736, 2015, Volume 387, Issue 10024, pp. 1163 - 1177
Summary Background Long-term hormone therapy has been the standard of care for advanced prostate cancer since the 1940s. STAMPEDE is a randomised controlled... 
Internal Medicine | ANDROGEN-DEPRIVATION THERAPY | MEDICINE, GENERAL & INTERNAL | PREDNISONE | DESIGN | MITOXANTRONE | CABAZITAXEL | CLINICAL-TRIALS | OPEN-LABEL | CHEMOTHERAPY | ENZALUTAMIDE | ESTRAMUSTINE | Survival analysis | Medical prognosis | Clinical trials | Hormone replacement therapy | Metastasis | Prostate cancer | Cancer therapies | Index Medicus | Abridged Index Medicus
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 08/2009, Volume 27, Issue 23, pp. 3742 - 3748
Purpose It has been postulated that castration-resistant prostate cancer (CRPC) commonly remains hormone dependent. Abiraterone acetate is a potent, selective,... 
LEUKEMIA GROUP-B | II CLINICAL-TRIALS | WORKING GROUP | ANTIANDROGEN WITHDRAWAL | ANDROGEN BIOSYNTHESIS | ONCOLOGY | STEROIDAL INHIBITORS | PHASE-II | END-POINTS | DOSE KETOCONAZOLE | HORMONAL-THERAPY | Steroid 17-alpha-Hydroxylase - antagonists & inhibitors | Prospective Studies | Humans | Middle Aged | Drug Resistance, Neoplasm | Male | Neoplasms, Hormone-Dependent - immunology | Androstenols - therapeutic use | Prostatic Neoplasms - immunology | Enzyme Inhibitors - administration & dosage | Antineoplastic Agents, Hormonal - therapeutic use | Aged, 80 and over | Testosterone - blood | Prostatic Neoplasms - drug therapy | Prostatic Neoplasms - pathology | Antineoplastic Agents, Hormonal - pharmacology | Drug Administration Schedule | Androstenols - pharmacology | Antineoplastic Agents, Hormonal - administration & dosage | Enzyme Inhibitors - pharmacology | Kaplan-Meier Estimate | Androgen Antagonists - pharmacology | Androstenes | Enzyme Inhibitors - therapeutic use | Disease Progression | Prostate-Specific Antigen - blood | Neoplasms, Hormone-Dependent - pathology | Androgen Antagonists - therapeutic use | Aged | Androstenols - administration & dosage | Androgen Antagonists - administration & dosage | Neoplasms, Hormone-Dependent - drug therapy | Adrenal Cortex Hormones - administration & dosage | Index Medicus
Journal Article
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2013, Volume 14, Issue 2, pp. 149 - 158
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2015, Volume 16, Issue 3, pp. 320 - 327
Journal Article
Journal Article